Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Glaucoma: Overview01:25

Glaucoma: Overview

488
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
488
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

378
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
378
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

420
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
420
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

5.5K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Short-Term Effect of Fast Forceful Abdominal Breathing Yoga in Eyes with Glaucoma.

Ophthalmology. Glaucoma·2026
Same author

Saccadic Reaction Times and Computational Modelling Reveal Heterogeneous Binocular Summation in Glaucomatous Visual Fields.

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)·2026
Same author

Visual field progression in varying severities of treated patients with primary angle closure glaucoma.

Scientific reports·2026
Same author

Artificial intelligence in glaucoma diagnosis and management: Has its time come?

Indian journal of ophthalmology·2026
Same author

Results of ocular biometry from a population-based study in detecting angle-closure disease in a clinical setting.

Indian journal of ophthalmology·2026
Same author

GWAS for primary angle-closure glaucoma identifies loci related to ocular biometry and morphology.

Nature communications·2025

相关实验视频

Updated: May 22, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.2K

在COVID-19期间眼光眼镜中视野进展.

Bhavini Johri1, Lingam Vijaya, Trupti Sudhir Patil

  • 1Smt. Jadhavbai Nathmal Singhvee Glaucoma Services Medical Research Foundation, Sankara Nethralaya, Chennai.

Journal of glaucoma
|March 12, 2025
PubMed
概括

玻璃眼患者在COVID-19大流行期间经历了加速视野进展. 这种恶化与降低药物坚持和可用性有关,突出显示需要持续监测.

科学领域:

  • 眼科医生 眼科 眼科
  • 公共卫生 公共卫生

背景情况:

  • 随着COVID-19的爆发,人们面临着前所未有的挑战,对医疗保健的准入和患者的坚持.
  • 绿眼的管理需要持续的监测和治疗,以防止不可逆转的视力丧失.

研究的目的:

  • 评估COVID-19大流行对绿眼病患者视野进展速度的影响.
  • 在大流行期间识别影响视野进展的因素.

主要方法:

  • 一项基于医院的前性队列研究包括234只眼睛,这些眼睛是患有青光眼或眼睛高血压的患者.
  • 患者在2020年3月前至少有五个和流行后两个汉弗雷视觉场 (24-2 SITA标准).
  • 用于基于趋势和事件的分析,使用了光眼进展分析软件;物流回归确定了进展因素.

主要成果:

  • 视野进展率在流行后显著增加,平均偏差 (MD) 和视野指数 (VFI) 恶化.
  • 45.3%的眼睛通过流行病后的趋势或事件分析显示出进展.
  • 流行病前的MD是流行病后进展的重要预测因素.

结论:

  • 与之前相比,在COVID-19大流行后,绿眼病患者表现出更高的视野进展率和比例.

更多相关视频

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
06:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

2.3K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.0K

相关实验视频

Last Updated: May 22, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.2K
Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
06:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

2.3K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.0K
  • 降低药物服药量和可用性可能是导致这种加速进展的因素.
  • 这些发现强调了连在公共卫生危机期间,持续治疗和监测眼的关键重要性.